PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT
Clinical trial NCT04165174 · UNKNOWN
Trial details
- NCT number
- NCT04165174
- Sponsor
- Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2020-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.